Featured
-
-
Perspective |
Genetically encodable materials for non-invasive biological imaging
This perspective describes recent developments in genetically encoded protein contrast agents for non-invasive biological imaging, namely ultrasound, magnetic resonance and optoacoustic imaging modalities.
- Arash Farhadi
- , Felix Sigmund
- & Mikhail G. Shapiro
-
-
Editorial |
Believing in seeing
Materials-based imaging agents are attractive candidates for a diverse range of imaging modalities and combined imaging–therapy applications, but economic implications and practical concerns remain obstacles to their clinical translation.
-
Commentary |
Tracking gene and cell fate for therapeutic gain
The preclinical intersection of molecular imaging and gene- and cell-based therapies will enable more informed and effective clinical translation. We discuss how imaging can monitor cell and gene fate and function in vivo and overcome barriers associated with these therapies.
- Nigel G. Kooreman
- , Julia D. Ransohoff
- & Joseph C. Wu
-
Commentary |
A targeted approach to cancer imaging and therapy
Nanoparticle-based imaging plays a crucial role in cancer diagnosis and treatment. Here, we discuss the modalities used for molecular imaging of the tumour microenvironment and image-guided interventions including drug delivery, surgery and ablation therapy.
- Chun Li
-